Grimaldi D, Hraiech S, Boutin E, Lacherade JC, Boissier F, Pham T, et al. Hypoxemia in the ICU: prevalence, treatment, and outcome. Ann Intensive Care 2018;8(1):82. DOI: 10.1186/s13613-018-0424-4.
Rice TW, Wheeler AP, Bernard GR, Hayden DL, Schoenfeld DA, Ware LB. Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest 2007;132(2):410–417. DOI: 10.1378/chest.07-0617.
Lu X, Jiang L, Chen T, Wang Y, Zhang B, Hong Y, et al. Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19. Respir Res 2020;21(1):1–4. DOI: 10.1186/s12931-020-01455-4.
Fukuda Y, Tanaka A, Homma T, Kaneko K, Uno T, Fujiwara A, et al. Utility of SpO2/FiO2 ratio for acute hypoxemic respiratory failure with bilateral opacities in the ICU. PLoS One 2021;16:1–11. DOI: 10.1371/journal.pone.0245927.
Babu S, Abhilash KPP, Kandasamy S, Gowri M. Association between SpO2/FiO2 Ratio and PaO2/FiO2 Ratio in Different Modes of Oxygen Supplementation. Indian J Crit Care Med 2021;25(9):1001–1005.
